ReviewThe Lancet regional health. Western Pacific2026
Consensus and controversy of liquid biopsy using circulating tumour DNA (ctDNA) for molecular residual disease detection in colorectal cancer.
Alicia Yioli Lefas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.